![Eli Lilly and Company / Nitroimidazoles / Organobromides / TH-302 / Gemcitabine / Doxorubicin / Bortezomib / Docetaxel / Sunitinib / Chemistry / Organic chemistry / Organofluorides Eli Lilly and Company / Nitroimidazoles / Organobromides / TH-302 / Gemcitabine / Doxorubicin / Bortezomib / Docetaxel / Sunitinib / Chemistry / Organic chemistry / Organofluorides](https://www.pdfsearch.io/img/0d07cf1cb220056ebf4a222ca11596bf.jpg)
| Open Document File Size: 414,39 KBShare Result on Facebook
Company EMD Serono Inc. / Threshold Pharmaceuticals Inc. / IND EOP2 STS SPA / Threshold Pharmaceuticals / / Event FDA Phase / / MedicalCondition melanoma / SCLC / febrile neutropenia / Cancer / Multiple Myeloma / gemcitabine EMR200592001 Pancreatic Cancer / pazopanib IST Hepatocellular carcinoma / Prevalent Feature Blood Vessels Hypoxic region Necrosis / Advanced leukemias / bortezomib IST Astrocytoma / Ph2 Ph3 Soft Tissue Sarcoma / Soft Tissue Sarcoma / Solid tumors / Thrombocytopenia / Pancreatic Cancer / mg/m2 Neutropenia / / Organization Inc. Pediatric Subcommittee / / Person Tillman Pearce / Antonio Gualberto / Robert Simon / / Position Director / EMD Serono / Medical Director / SVP Regulatory Affairs / Senior Medical Director / / Product TH-302 / /
SocialTag |